EFNS guidelines for the diagnosis and management of Alzheimer’s disease
Open Access
- 13 September 2010
- journal article
- practice guideline
- Published by Wiley in European Journal of Neurology
- Vol. 17 (10), 1236-1248
- https://doi.org/10.1111/j.1468-1331.2010.03040.x
Abstract
Background and objectives: In 2008 a task force was set up to develop a revision of the European Federation of the Neurological Societies (EFNS) guideline for the diagnosis and management of Alzheimer’s disease (AD) and other disorders associated with dementia, published in early 2007. The aim of this revised international guideline was to present a peer‐reviewed evidence‐based statement for the guidance of practice for clinical neurologists, geriatricians, psychiatrists, and other specialist physicians responsible for the care of patients with AD. Mild cognitive impairment and non‐Alzheimer dementias are not included in this guideline. Methods: The task force working group reviewed evidence from original research articles, meta‐analysis, and systematic reviews, published before May 2009. The evidence was classified and consensus recommendations graded (A, B, or C) according to the EFNS guidance. Where there was a lack of evidence, but clear consensus, good practice points were provided. Results: The recommendations for clinical diagnosis, blood tests, neuropsychology, neuroimaging, electroencephalography, cerebrospinal fluid (CSF) analysis, genetic testing, disclosure of diagnosis, treatment of AD, behavioural and psychological symptoms in dementia, legal issues, counselling and support for caregivers were all revised as compared with the previous EFNS guideline. Conclusion: A number of new recommendations and good practice points are made, namely in CSF, neuropsychology, neuroimaging and reviewing non‐evidence based therapies. The assessment, interpretation, and treatment of symptoms, disability, needs, and caregiver stress during the course of AD require the contribution of many different professionals. These professionals should adhere to these guideline to improve the diagnosis and management of AD.Keywords
This publication has 87 references indexed in Scilit:
- Ginkgo biloba for Prevention of DementiaA Randomized Controlled TrialJAMA, 2008
- A Three-Country Randomized Controlled Trial of a Psychosocial Intervention for Caregivers Combined With Pharmacological Treatment for Patients With Alzheimer Disease: Effects on Caregiver DepressionAmerican Journal of Geriatric Psychiatry, 2008
- Amyloid-β immunisation for Alzheimer's diseaseThe Lancet Neurology, 2008
- Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialThe Lancet Neurology, 2008
- Detecting Dementia With the Mini-Mental State Examination in Highly Educated IndividualsArchives of Neurology, 2008
- Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's diseaseJournal of the International Neuropsychological Society, 2008
- Community occupational therapy for older patients with dementia and their care givers: cost effectiveness studyBMJ, 2008
- Sensitivity and Specificity of the Mini‐Mental State Examination for Identifying Dementia in the Oldest‐Old: The 90+ StudyJournal of the American Geriatrics Society, 2007
- The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screeningInternational Journal of Geriatric Psychiatry, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005